Rapid Internal Control Reference Recombinase-Aided Amplification Assays for EBV and CMV Detection.

Biomed Environ Sci

NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China;Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, Hubei China.

Published: August 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Epstein-Barr virus (EBV) and cytomegalovirus (CMV), two of the most prevalent human herpesviruses, cause a wide spectrum of diseases and symptoms and are associated with serious health problem. In this study, we developed an internal control reference recombinase-aided amplification (ICR-RAA) assay for the rapid detection of EBV and CMV within 30 min. The assay had a sensitivity of 5 and 1 copies/test for EBV and CMV, respectively, with no cross reaction with other pathogens. In comparison with those of the commercial quantitative polymerase chain reaction (qPCR), the sensitivity of the EBV and CMV ICR-RAAs using extracted DNA was 93.33% and 84.84%, respectively; the specificity was 98.75% and 100.00%, respectively; and the Kappa values were 0.930 and 0.892 ( < 0.05), respectively. In comparison with those of qPCR, the sensitivity of the EBV and CMV ICR-RAAs using the DNA by thermal lysis was 72.22% and 80.00%, respectively; the specificity was 100.00%; and the Kappa values were 0.764 and 0.878 ( < 0. 05), respectively. Thus, rapid and specific detection of EBV and CMV is possible using ICR-RAA assays.

Download full-text PDF

Source
http://dx.doi.org/10.3967/bes2021.091DOI Listing

Publication Analysis

Top Keywords

ebv cmv
24
internal control
8
control reference
8
reference recombinase-aided
8
recombinase-aided amplification
8
detection ebv
8
qpcr sensitivity
8
sensitivity ebv
8
cmv icr-raas
8
10000% kappa
8

Similar Publications

Cytomegalovirus and Epstein-Barr Virus reactivation in steroid-refractory immune checkpoint inhibitor colitis.

J Infect Dev Ctries

August 2025

Gastroenterology Division, Internal Medicine Department, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (UMC), Muscat, Sultanate of Oman.

Introduction: Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivation are known complications in immunocompromised hosts, particularly transplant recipients. However, their occurrence and clinical implications in patients with solid tumors remain underexplored. The introduction of immune checkpoint inhibitors (ICIs) has transformed cancer therapy, but immune-related adverse events (irAEs), including colitis, are increasingly recognized.

View Article and Find Full Text PDF

When viral myocarditis meets thrombosis tendency: deep analysis of a complex case report.

Front Cardiovasc Med

August 2025

Department of Cardiology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

This case report presents a 43-year-old male patient with severe symptoms who was admitted due to dyspnea following physical activity, cough accompanied by fever, lower limb edema, and hemoptysis. The patient had a 20-year history of hypertension. Examinations revealed bilateral lower pulmonary artery thrombosis, a left ventricular thrombus, pulmonary infarction, and reduced left ventricular systolic function, with a lowest left ventricular ejection fraction (LVEF) of 26.

View Article and Find Full Text PDF

Background: From a public health perspective it is remarkable that there are yet no longitudinal studies in the general population investigating the influence of the basal immune state, measured before the pandemic, on the risk of SARS-CoV-2 infection and COVID-19.

Objective: To investigate the specific and combined effects of personal levels of cytokines and immunoglobulins-measured in individuals' blood 4 years before the pandemic-on the risk of SARS-CoV-2 infection and COVID-19 in a general population.

Methods: We conducted a prospective cohort study in 240 individuals from the general population of Barcelona.

View Article and Find Full Text PDF

Purpose: Relapse remains the leading cause of treatment failure in high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome-IB (MDS-IB) patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ruxolitinib has demonstrated antileukemic activity , and decitabine has been found to be tolerable when combined with modified busulfan-cyclophosphamide (mBu/Cy) conditioning regimen. Here, we investigated the efficacy of ruxolitinib and decitabine plus a mBu/Cy conditioning regimen (Rux-Dec-mBu/Cy) in reducing relapse in high-risk AML/MDS patients ().

View Article and Find Full Text PDF

Gianotti-Crosti Syndrome (GCS) is a benign, self-limited dermatologic condition that predominantly affects pediatric patients. It is most commonly associated with viral infections; however, reports implicating Influenza A virus (IAV) as an etiological agent are exceedingly rare. We report the case of a previously healthy two-year-old girl who presented with fever, rhinorrhea, and a symmetric papulovesicular rash involving the extremities, face, and trunk.

View Article and Find Full Text PDF